- Advertisement -
The US consumer health company and parent of Neutrogena narrowly missed Wall Street estimates for second-quarter results as tariffs and currency-related costs offset sales gains.
Click here to view the original article.
Kenvue Misses Estimates as Inflation, Tariffs Squeeze Margins
- Advertisment -
